-
Phase 1b data for alzheimer’s disease treatment aducanumab announced
- August 29, 2018
- Posted by: PharmaScroll
- Category:
No Comments -
Eisai and Biogen report positive results for Alzheimer’s drug BAN2401
- July 8, 2018
- Posted by: PharmaScroll
- Category: